Deputy Speaker, indeed we succeeded in decreasing the number of pulmonary TB cases between 2009 and 2010 by 1,1%. This decline also applies to extrapulmonary TB. Since February 2011, we started an active community-based care funding initiative on a large scale. Significant progress has been made with the diagnosis of TB. Whereas in the past we used to rely on microscopy - and that would take days; or on sputum cultures, which would take weeks - we are now rolling out GeneXpert technology, which enables us to diagnose TB within a period of two hours. Currently the GeneXpert detects TB on an average of 17% of tested subjects, compared to between 4% and 9% when we were using the old method. I thank you.